ArriVent BioPharma Reports First Quarter 2026 Financial Results

Go back to ArriVent BioPharma Reports First Quarter 2026 Financial Results
(NASDAQ: AVBP) Delayed: 28.45 -1.65 (5.48%)
Previous Close $30.10    52 Week High $ 
Open $30.16    52 Week Low $ 
Day High $30.55    P/E N/A 
Day Low $28.43    EPS $ 
Volume 653,155